🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Online today in nature - our latest study led by superstar postdoc Gilles Rademaker detailing the role of PSCK9 in driving sterol dependent metastatic organ choice in pancreatic cancer nature.com/articles/s4158… full text available here 👉 rdcu.be/em0VG and thread 👇

New weekly Annals of Surgical Oncology featured article: Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma.  ow.ly/3Lwi50VCXJG #ASOFeaturedArticle

Elraglusib + GnP vs GnP mPDAC #ASCO25 🔎GSK inhibitor 👉ORR 29 vs 21% 👉mPFS 5.6 vs 5.1 mo 👉mOS 10.1 vs 7.2 mo 🧐 Novel & interesting MOA, but open label, more tox... more data required ESMO - Eur. Oncology

🔥🚨OncoAlert Hot off the press. Just published NEJM in conjunction with presentation ASCO #ASCO25 Results of #Challenge trial of: Structured #Exercise after adjuvant chemotherapy for #ColonCancer: ✅⬆️Disease-free survival ✅⬆️Overall survival 👇🏻 nejm.org/doi/full/10.10…

#ASCO25 Important publication on the treatment of locally advanced gallbladder cancer (GBC) The phase III POLCA-GB trial demonstrates that neoadjuvant chemoradiation (CRT) doubles survival compared to chemotherapy alone: ⬇️⬇️ OncoAlert ASCO

So you've heard the practice changing exercise CHALLENGE trial! But what did that groundbreaking exercise program actually look like day-to-day? Let's explore the "Structured Exercise Program" based on info from their paper supplement on NEJM #ASCO2025 #ASCO25 1/10

If you’re a GI/HPB surgeon/oncologist who couldn’t make it to ASCO 2025 & trying to scour for its ongoings online like I have been, here’s the 2 trials you’d probably be interested in with a concise breakdown: MATTERHORN, & CASSANDRA! (Also tagging ppl who are smarter than me)

Appreciate you Tim! Lots of support and work from an incredible team of collaborators. Really grateful for all I learned, especially from Brekkenlab & Huocong Huang UTSW Simmons Cancer Center UTSW Surgery

Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4jyRiED

From the #SSAT2025 Annual Meeting: The Doris and John L. Cameron Guest Oration Dr. Herbert Zeh III of UT Southwestern delivered a powerful talk titled "Breaking Down the Tape: Using Video Review and Robotics to Advance Pancreatic Surgery." #SSAT2025 Herbert Zeh UTSW Surgery

The advent of next-generation sequencing and the development of gene- and immune-targeted therapies have begun to transform the treatment landscape for hepatobiliary cancers. ja.ma/4kZamgD

wow. this means so much to me truly….french open champion🥹 i worked so hard for this moment and for it to have happened is insane. thank you God ❤️ and thank you everyone. this means the world…. I ‘m still in shock honestly can’t find the words but all I can say for now is

So when physicians LEAD hospitals, hospitals perform better. Guess what else is true…. When physicians control the board room, hospitals perform better as well. Let’s end the silliness of blocking doctors from owning hospitals. Repeal Section 6001. journals.lww.com/jaaos/fulltext…

🇨🇦 in #eahpba2025 champions league 🏆 HELIX RCT of TXA vs placebo for hepatectomy by Paul Karanicolas No change in 🩸transfusion but ⬆️ morbidity with TXA ⚠️ don’t use TXA for hepatectomy See 📝 JAMA 👉🏻 jamanetwork.com/journals/jama/…

June Issue: Preoperative Prognostic Factors in Resectable #PancreaticCancer : State of the Art and Prospects rdcu.be/eqPyF Gilbert Z Murimwa, M.D. Syed A. Ahmad

Congrats Alexandra Gangi, MD !!!

Bravo Ifeanyichukwu Ogobuiro, MD, MHS 👏🏾👏🏾👏🏾

Incredible

Absolute honor to match at MSK. NYC here we come!

6 years later, hard work pays off. Surreal matching at my dream fellowship. Thankful for Herbert Zeh Adam Yopp Patricio Polanco and all my mentors UTSW Surgery and elsewhere. Wouldn't have made it here without them